Transforming growth factor-alpha: a surrogate endpoint biomarker? (Q44095358)

29 November 2017

Transforming growth factor-alpha: a surrogate endpoint biomarker? (English)

1 reference

29 November 2017

0 references

Samuel W Beenken

1

1 reference

29 November 2017

Richard Hockett

2

1 reference

29 November 2017

William Grizzle

3

1 reference

29 November 2017

Heidi L Weiss

4

1 reference

29 November 2017

Allan Pickens

5

1 reference

29 November 2017

Marjorie Perloff

6

1 reference

29 November 2017

Winfred F Malone

7

1 reference

29 November 2017

Kirby I Bland

8

1 reference

29 November 2017

1 August 2002

1 reference

Journal of the American College of Surgeons

29 November 2017

1 reference

29 November 2017

195

1 reference

29 November 2017

2

1 reference

29 November 2017

149-158

1 reference

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

1 reference

7 January 2021

Effect of retinoids on oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Simultaneous quantitation of multiple cytokine mRNAs by RT-PCR utilizing plate based EIA methodology

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Molecular themes in oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Dimerization of cell surface receptors in signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Autoregulatory mechanisms in protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Protein modules and signalling networks

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Production of TGF-alpha and TGF-beta by cultured keratinocytes, skin and oral squamous cell carcinomas--potential autocrine regulation of normal and malignant epithelial cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

EGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

TGF-alpha and EGF-receptor mRNAs in human oral cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Quantitative assay of epidermal growth factor receptor in human squamous cell carcinomas of the oral region by an avidin-biotin method

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erbB-2 and c-myc

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Expression of scatter factor and c-met receptor in benign and malignant breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901219-X

7 January 2021

10.1016/S1072-7515(02)01219-X

Identifiers

DOI

1 reference

29 November 2017

1 reference